58 results
8-K
EX-99.1
IKT
Inhibikase Therapeutics Inc
30 Apr 24
Regulation FD Disclosure
8:17am
. Parkinson’s: Slowly Progressing MSA: Rapidly Progressing 1/3 of a Patient’s Lifespan to death = 25 years 1/10 of a Patient’s Lifespan to death = 8 years Global
8-K/A
IKT
Inhibikase Therapeutics Inc
2 Apr 24
Departure of Directors or Certain Officers
5:12pm
”), or (iii) as a result of his Resignation, death or Disability (each as defined in the Employment Agreement), then he will be entitled to receive:
Any
8-K/A
EX-99.1
x78dxunf
2 Apr 24
Departure of Directors or Certain Officers
5:12pm
424B3
oe00zpi kh
4 Apr 23
Prospectus supplement
4:57pm
POS AM
26j91 qqzkt2u6bxco
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
PRE 14A
kh0m80a72zusfvz
21 Apr 22
Preliminary proxy
4:33pm
424B4
31y2h68nut njniij
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
djbduyz1ex5crpabh3a7
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
DRS
EX-1.1
yc1g168fy1rcoirmh
2 Jun 21
Draft registration statement
12:00am